Common questions about Fosamax 70 mg (FAQ)
Q: What is the main reason doctors prescribe Fosamax 70 mg?
A: Fosamax 70 mg is officially prescribed for the treatment of osteoporosis in postmenopausal women. The medication is also indicated to help increase bone mass in men who have been diagnosed with osteoporosis, according to regulatory documents.
Q: How quickly does Fosamax 70 mg start to show effects on bones?
A: Research indicates that the active ingredient may begin to interact with bone tissue shortly after being absorbed into the body. However, measurable effects, such as a change in bone mineral density (BMD), may not be observed for several months or more of continued use.
Q: How long do most people stay on Fosamax 70 mg?
A: The official product information states that the optimal duration of treatment has not yet been definitively established. For this reason, regulatory guidance advises that the need for continued treatment should be periodically re-evaluated by a healthcare professional, especially after use extending past five years.
Q: Is it true that Fosamax 70 mg can affect the jawbone?
A: Yes. Severe osteonecrosis of the jaw (ONJ) is documented in regulatory safety information as a rare, serious adverse reaction associated with bisphosphonates. Official documentation often associates this risk with prolonged treatment periods.
Q: Is it okay to have dental work done while taking Fosamax 70 mg?
A: Regulatory guidance suggests a dental examination should be performed before starting Fosamax. It is noted in patient information that individuals should make their dentist aware of the medication, particularly before invasive procedures such as tooth extractions.
Q: Is there a link between Fosamax 70 mg and unusual fractures?
A: Official regulatory documents indicate a link between bisphosphonates and atypical femoral fractures. These are described as low-trauma fractures occurring in the shaft of the femur (thigh bone) and are classified as a rare, serious adverse reaction.
Q: Can I take calcium supplements at the same time as Fosamax 70 mg?
A: The official label information advises against taking Fosamax concurrently with products containing multivalent cations (like calcium supplements or antacids). A separation of at least 30 minutes is specified because taking them together would interfere with the absorption of the medicine, reducing its effectiveness.
Q: Does the generic version (alendronate) work exactly the same as Fosamax?
A: Regulatory agencies require that generic versions of a drug, such as alendronate, demonstrate bioequivalence to the brand-name product, Fosamax. This means the generic must deliver the active ingredient to the body at the same rate and extent as the original medicine.
Q: How does the body eliminate Fosamax 70 mg?
A: Fosamax is a compound that is not metabolized (broken down) by the body. The portion of the drug that is absorbed is primarily excreted unchanged by the kidneys (renal route). The majority of the dose taken orally is not absorbed and passes through the body via the feces.
Q: Does Fosamax 70 mg help with joint pain or only bone density?
A: Fosamax is indicated for treating conditions involving bone density loss, not joint pain. However, official documents list musculoskeletal pain (including pain in the joints) as a common adverse reaction that can range from mild to severe.
Q: Is Fosamax 70 mg for women only, or can men take it?
A: According to regulatory indications, Fosamax 70 mg is used in both postmenopausal women and men for the treatment of osteoporosis.
Q: What happens if I miss a weekly dose of Fosamax 70 mg?
A: If a weekly dose is forgotten, regulatory instructions advise taking a single tablet on the morning after the dose is remembered. Patients are instructed not to take two tablets on the same day; the original weekly schedule is intended to be resumed the following week.
Q: Is Fosamax 70 mg considered a steroid?
A: No. Fosamax (alendronate) belongs to the drug class known as bisphosphonates. These are a distinct class of medicines and are not the same as steroids (corticosteroids). Fosamax is sometimes used to address bone loss that may be caused by long-term steroid therapy.
Q: Does Fosamax 70 mg interact with common pain relievers like ibuprofen or aspirin?
A: Regulatory documents advise caution when taking Fosamax concurrently with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen or aspirin. This is due to a potential increased risk of upper gastrointestinal adverse reactions when these medicines are used together.
Q: Do I need to take Vitamin D while on Fosamax 70 mg?
A: Official guidance emphasizes that patients should have adequate levels of calcium and vitamin D before starting and during treatment. Regulatory guidance suggests that supplemental calcium and vitamin D should be considered for individuals whose dietary intake is insufficient.
Q: Is it normal to have mild muscle aches after starting Fosamax 70 mg?
A: Official regulatory documents list musculoskeletal pain as a common adverse reaction associated with this medication. This pain can vary in intensity and may appear anywhere from one day to several months after starting the treatment.
Q: Can Fosamax 70 mg cause problems with swallowing?
A: Yes, it can. The medication is contraindicated in patients with conditions that delay esophageal emptying. Serious, rare adverse reactions like esophagitis, ulcers, or erosion of the esophagus are documented, which may be related to difficulty or pain when swallowing.
Q: Does Fosamax 70 mg affect fertility or hormone levels?
A: Official Canadian regulatory documents state that the effect of Fosamax on human fertility has not been fully evaluated. The medicine is not indicated for use in women who are pregnant or breast-feeding.
Q: Is the 70 mg tablet stronger than the daily tablet?
A: The 70 mg once-weekly dose is considered therapeutically equivalent to the 10 mg once-daily dose for efficacy. Official studies indicate that both doses produce a similar therapeutic effect in increasing bone mineral density; the difference lies only in the convenience of the weekly dosing schedule.
Q: Can long-term use of Fosamax 70 mg cause any serious side effects?
A: Yes. Serious adverse reactions such as osteonecrosis of the jaw (ONJ) and atypical femoral fractures are noted in regulatory information as being generally associated with the prolonged use of bisphosphonate medications.
Q: What does the research say about stopping Fosamax 70 mg after a few years?
A: Research has examined the effects of treatment discontinuation. Official regulatory guidance notes that the need for continued therapy is intended to be periodically re-evaluated by a healthcare professional, particularly after treatment duration reaches five or more years.
Q: Can Fosamax 70 mg make me feel dizzy or tired?
A: Some official post-marketing reports have documented adverse reactions such as dizziness and fatigue (unusual tiredness or weakness). However, their incidence is generally reported in regulatory documents as not known or rare.
Q: What is the safety profile of Fosamax 70 mg in older adults?
A: Clinical studies have specifically examined the use of Fosamax in the elderly. These studies have shown no age-related differences in the efficacy or overall safety profiles, meaning no dosage adjustment is typically necessary for older adults.
Q: Why do official materials advise against taking Fosamax 70 mg with mineral water?
A: Official instructions advise taking the tablet only with plain water. This is because mineral water contains multivalent cations (minerals) that can bind to the medicine, leading to a significantly reduced absorption of alendronate and limiting its therapeutic effect.
